Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional study

World J Gastroenterol. 2014 Sep 7;20(33):11865-70. doi: 10.3748/wjg.v20.i33.11865.

Abstract

Aim: To investigate the association between serum alpha-fetoprotein (AFP) levels and fatty liver disease (FLD) in a Chinese population.

Methods: A cross-sectional study was performed among subjects who presented for a health examination at the First Affiliated Hospital, College of Medicine, Zhejiang University in 2013. FLD was diagnosed based on an ultrasonography examination. Serum AFP levels were measured with a chemiluminescence immunoassay.

Results: Of the 9800 subjects enrolled, 2601 were diagnosed with FLD. Subjects with FLD had higher serum AFP levels than those without the disease. Subjects with high serum AFP levels had a higher prevalence of FLD, metabolic syndrome, and its components. Univariate logistic analysis showed that elevated serum AFP levels were associated with an increased risk of FLD (OR = 1.057, 95%CI: 1.031-1.084). However, after adjusting for covariates, AFP no longer remained significantly associated with the risk factors for FLD.

Conclusion: Our results suggest that serum AFP levels are significantly associated with FLD and that AFP acts as a cofactor, but not as an independent factor, for FLD.

Keywords: Alpha-fetoprotein; Association; Fatty liver; Obesity; Risk factor.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Chi-Square Distribution
  • China / epidemiology
  • Cross-Sectional Studies
  • Fatty Liver / blood*
  • Fatty Liver / diagnostic imaging
  • Fatty Liver / epidemiology
  • Female
  • Humans
  • Logistic Models
  • Male
  • Metabolic Syndrome / epidemiology
  • Middle Aged
  • Multivariate Analysis
  • Prevalence
  • Risk Factors
  • Ultrasonography
  • Up-Regulation
  • alpha-Fetoproteins / analysis*

Substances

  • AFP protein, human
  • Biomarkers
  • alpha-Fetoproteins